Key Information
- About us
- Why choose us?
- Our Accreditations
- Key team members
- Serious injury links
- Serious injury case studies
- Serious injury testimonials
The help & support we provide
- Serious injury services
- Serious injury compensation
- Serious injury case process
- Case funding
- Chosen the wrong solicitor?
Further research resources
First US stem cell transplant into spinal cord completedRSS Feed
A patient with a neurodegenerative disease has received the first spinal cord stem cell treatment in the US, which, if effective, could potentially help in treating spinal cord injuries.
The patient has amyotrophic lateral sclerosis (ALS), which causes the deterioration of motor neurons in the brain and spinal cord.
Biotherapeutics company Neuralstem Incorporated developed the stem cells that were used and plans to treat a further 17 patients as part of this clinical trial.
Although this trial is targeting ALS, the company is also developing potential treatments for ischemic spastic paraplegia, traumatic spinal cord injury and Huntington's disease.
"Our scientists have worked tirelessly to bring our discovery of adherent neural stem cells from the bench to the bedside," said Dr Karl Johe, chairman of the board and chief scientific officer at Neuralstem, and the inventor of the technology.
Biopharmaceutical company Geron is currently developing a human embryonic stem cell (hESC)-based product as a treatment for spinal cord injury.
Serious Law, leading spinal cord injury solicitors
Ex-Olympic skier speaks of success despite spinal injury
Man with spinal injury rewarded for community work
Spinal injury patients could walk again thanks to therapy involving blue light
To visit our most popular resources click here
